Termite foe BioProspect eyes off emu oil product range [ + ]

Graham Macdonald permanent chair of ASCC board of directors [ + ]

Elsevier published six ‘fake’ Australian medical journals on behalf of pharma companies [ + ]

The Australian Academy of Science 2009 winners of distinguished awards for scientific excellence have been announced.

Climate change, clean energy research and best practice approaches for providing expert advice to government were among the topics discussed when Prof Penny Sackett met with key US scientific advisers.

Cochlear, CSL, ResMed, Pharmaxis, Novogen, SciGen [ + ]

The study of biology reveals some truly amazing and quite nifty feats of biochemical engineering, and none less so than the way in which parasitic microorganisms invade their host. [ + ]

Novogen has developed a technology platform based on synthetic isoflavones that promises compounds which can kill cancer cells without harming healthy cells. [ + ]

COH, CSL, RMD, Pharmaxis, Sonic Healthcare, Avexa, Cellestis [ + ]

Positive data from Pharmaxis’ Phase III trial in cystic fibrosis [ + ]

Research Australia has published 'Trends in Health and Medical Research Funding', a statistical overview of expenditure on health and medical research by government, industry and philanthropy.

Brisbane biotech Implicit Bioscience has developed a business model unusual in Australia: it aims to return money to investors. [ + ]

Melbourne agbiotech Hexima has been making waves with its fungal and insect-resistance technology and a tasty deal with DuPont. [ + ]

Biota, CSL, Hexima, Alchemia, Mesoblast [ + ]

Mesoblast approved for Phase II trail for cervical spine fusion [ + ]